Breaking News Instant updates and real-time market news.

MRSN

Mersana Therapeutics

$5.92

0.55 (10.24%)

08:40
11/27/18
11/27
08:40
11/27/18
08:40

Mersana Therapeutics appoints Dirk Huebner CMO

Mersana Therapeutics announced the appointment of Dirk Huebner to the position of CMO. Huebner brings to this position 25 years of drug development experience including experience in the development and approval of ADCs. Prior to joining Mersana, Huebner served as VP, head of development, for Boston Biomedical, where he built a robust clinical development team and oversaw the clinical development of several early stage compounds.

MRSN Mersana Therapeutics
$5.92

0.55 (10.24%)

09/17/18
JPMS
09/17/18
NO CHANGE
JPMS
Neutral
Mersana partial hold being lifted removes 'worst case scenario,' says JPMorgan
After Mersana announced that the FDA lifted the partial clinical hold on XMT1522 after reaching alignment on protocol changes, JPMorgan analyst Jessica Fye said the resolution of the partial hold was generally expected but still removes a "worst case scenario." Given the amendments increasing the time interval between dose escalation cohorts, she sees longer timelines to select the go-forward dose for XMT-1522. While Fye sees a potentially attractive opportunity for Mersana's ADC platform, she thinks patience will be required before generation of proof-of-concept data for XMT1522 and keeps a Neutral rating on Mersana shares.
09/17/18
HCWC
09/17/18
NO CHANGE
Target $23
HCWC
Buy
H.C. Wainwright boosts Mersana price target to $23 amid 23% selloff
H.C. Wainwright analyst Debjit Chattopadhyay raised his price target for Mersana Therapeutics to $23 after the company disclosed plans to reinstate dosing of new patients following the FDA's decision to lift the partial clinical hold on XMT-1522. The selloff in shares today could be related to the step back in development speed, which likely pushes relevant comparisons with peer sponsored programs into mid-2019, as well as the stock's 30% run-up since the partial clinical hold was disclosed on July 19, Chattopadhyay tells investors in a research note. The analyst says his new price target represents the XMT-1522 clinical program with "modest probabilities of success addressed in the valuation segment." He keeps a Buy rating on Mersana Therapeutics. The stock in midday trading is down 23%, or 3.32, to $11.06.
11/14/18
LEER
11/14/18
UPGRADE
LEER
Outperform
Mersana Therapeutics upgraded to Outperform from Market Perform at Leerink
11/14/18
11/14/18
UPGRADE
Target $14

Outperform
Mersana Therapeutics upgraded to Outperform on valuation at Leerink
As previously reported, Leerink analyst Jonathan Chang upgraded Mersana Therapeutics to Outperform from Market Perform, with $14 price target. The analyst cited valuation as the stock is trading at historic lows. Chang notes that the company reported Q3 financial results and provided a pipeline update that was largely in-line with expectations, and points out that the next key catalysts for the stock will be initial XMT-1536 Phase I dose-escalation data in 1H19 and potential XMT-1522 Phase I update in mid-2019.

TODAY'S FREE FLY STORIES

CAG

Conagra Brands

$29.95

0.3 (1.01%)

14:55
09/20/19
09/20
14:55
09/20/19
14:55
Options
ConAgra put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 01

    Oct

14:50
09/20/19
09/20
14:50
09/20/19
14:50
General news
Fed's Kaplan said he backed the Fed's rate cuts in September and July »

Fed's Kaplan said he…

FB

Facebook

$189.71

-0.44 (-0.23%)

14:48
09/20/19
09/20
14:48
09/20/19
14:48
Hot Stocks
Facebook says has suspended 'tens of thousands' of apps over data use »

In a blog post, Facebook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 24

    Sep

  • 27

    Oct

SKT

Tanger Factory

$15.90

0.13 (0.82%)

14:35
09/20/19
09/20
14:35
09/20/19
14:35
Options
Tanger Factory put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:35
09/20/19
09/20
14:35
09/20/19
14:35
General news
Action Economics Survey results: »

Action Economics Survey…

USAT

USA Technologies

$7.43

-0.22 (-2.88%)

14:31
09/20/19
09/20
14:31
09/20/19
14:31
Hot Stocks
Breaking Hot Stocks news story on USA Technologies »

USA Technologies trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USAT

USA Technologies

$7.43

-0.22 (-2.88%)

14:28
09/20/19
09/20
14:28
09/20/19
14:28
Hot Stocks
USA Technologies says unlikely to meet Nasdaq deadline for filing compliance »

USA Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USAT

USA Technologies

$7.43

-0.22 (-2.88%)

14:26
09/20/19
09/20
14:26
09/20/19
14:26
Hot Stocks
Breaking Hot Stocks news story on USA Technologies »

USA Technologies trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FISV

Fiserv

$104.82

-0.03 (-0.03%)

14:25
09/20/19
09/20
14:25
09/20/19
14:25
Options
Fiserv call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 27

    Oct

TD

Toronto-Dominion

$57.97

0.4 (0.69%)

, DB

Deutsche Bank

$8.02

-0.055 (-0.68%)

14:24
09/20/19
09/20
14:24
09/20/19
14:24
Hot Stocks
TD accepted Epstein accounts after Deutsche cut ties, Bloomberg says »

Canadian lender…

TD

Toronto-Dominion

$57.97

0.4 (0.69%)

DB

Deutsche Bank

$8.02

-0.055 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

IVV

iShares Core S&P 500

$301.93

-0.845 (-0.28%)

, SPY

SPDR S&P 500 ETF Trust

$298.77

-0.906381 (-0.30%)

14:22
09/20/19
09/20
14:22
09/20/19
14:22
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

ETF fund flows to the top…

IVV

iShares Core S&P 500

$301.93

-0.845 (-0.28%)

SPY

SPDR S&P 500 ETF Trust

$298.77

-0.906381 (-0.30%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$87.41

0.05 (0.06%)

IEF

iShares 7-10 Year Treasury Bond ETF

$111.69

0.335 (0.30%)

ITE

SPDR Bloomberg Barclays Intermediate Term Treasury ETF

$62.19

0.065 (0.10%)

SPTL

SPDR Portfolio Long Term Treasury ETF

$40.45

0.12 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
09/20/19
09/20
14:17
09/20/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
09/20/19
09/20
14:16
09/20/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDD

Pinduoduo

$33.65

-0.98 (-2.83%)

14:15
09/20/19
09/20
14:15
09/20/19
14:15
Options
Pinduoduo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$4.00

0.3347 (9.13%)

14:11
09/20/19
09/20
14:11
09/20/19
14:11
Periodicals
Fitbit deciding whether to explore sale, Reuters says »

Fitbit (FIT) has held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$3.69

0.025 (0.68%)

14:07
09/20/19
09/20
14:07
09/20/19
14:07
Hot Stocks
Fitbit rises after report of hiring bank to consider sale »

Shares of Fitbit are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$3.73

0.06 (1.64%)

14:03
09/20/19
09/20
14:03
09/20/19
14:03
Periodicals
Breaking Periodicals news story on Fitbit »

Fitbit in talks with bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$122.80

-5.865 (-4.56%)

13:55
09/20/19
09/20
13:55
09/20/19
13:55
Options
Wayfair put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DELL

Dell Technologies

$52.26

-0.8 (-1.51%)

13:53
09/20/19
09/20
13:53
09/20/19
13:53
Conference/Events
Dell Technologies to hold a business news update meeting »

CFO Sweet, along with SVP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Nov

FTR

Frontier Communications

$1.00

-0.0006 (-0.06%)

13:43
09/20/19
09/20
13:43
09/20/19
13:43
Periodicals
Frontier Communications prepares for debt restructuring talks, WSJ reports »

Frontier Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:40
09/20/19
09/20
13:40
09/20/19
13:40
General news
U.S. equity markets »

U.S. equity markets were…

BTU

Peabody Energy

$15.47

-1.56 (-9.16%)

, ARCH

Arch Coal

$71.00

-5.37 (-7.03%)

13:39
09/20/19
09/20
13:39
09/20/19
13:39
Hot Stocks
Peabody Energy confirms commitment to pending PRB/Colorado joint venture »

Peabody (BTU) confirmed…

BTU

Peabody Energy

$15.47

-1.56 (-9.16%)

ARCH

Arch Coal

$71.00

-5.37 (-7.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

SPY

SPDR S&P 500 ETF Trust

$298.09

-1.586381 (-0.53%)

, SPX

S&P 500

$0.00

(0.00%)

13:34
09/20/19
09/20
13:34
09/20/19
13:34
Periodicals
Chinese delgation cancels farm trip to Montana, Reuters reports »

Chinese officials that…

SPY

SPDR S&P 500 ETF Trust

$298.09

-1.586381 (-0.53%)

SPX

S&P 500

$0.00

(0.00%)

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

NDX

Nasdaq 100 Index

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RACE

Ferrari

$151.80

-1.95 (-1.27%)

13:30
09/20/19
09/20
13:30
09/20/19
13:30
Options
Trader trims risk by legging out of iron condor in Ferrari »

Trader trims risk by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$29.05

-0.01 (-0.03%)

13:25
09/20/19
09/20
13:25
09/20/19
13:25
Options
MGM Resorts call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.